Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
eNq1mFFv2jAQx9/5FFHeSYAVClOg2li7Ia0ao0Wb9lKZ5Chmxk7PNtB++jmEbnRy1NbUj4mT/13u/v75lORsu2LBGlBSwfthM2qEAfBUZJTf9sPp9UW9G54NasmSrMnBY6dRI2q2wiBlRMp+WKxGMyBcRj8vv34C8z5gOKgFiZgtIVVPntOKsugLkYtLkhfPBMla0CxYgVqIrB/mWu3uBolUaLIYbAT+ljlJIYn3dw5Xlzcnh/eTuBB7gaqWgF8Jv7WKAnfSTDUicDUkCm4F3lul5+lNq3vaaTS6TiGonIAUGlMYE7UYo1jTDDJ7JMIkOAWZb7IrwDUDVQSxisfLdCWdxMmSbCdwN7In/cGsDtVW1Rv15mlRpk671+q1e06h8KBUdvOYj4hNQ3qddrfTioHHClLTQaR3ddPEB8Hog16RmWOrxgIVYZ6aROXwqd08xUG4e9YMGZU5I/fRUuaupSJIzDKggYK/Dym+4BoNppip2X/6XDMWvzLr6R4injIuGDUU2vjRzpKLiWshhoIr2FZ31A1/arv3IgX5drIPgtvRP9YzRlNXwhkGaZBqOhlVA84jGz4SCVP0B4cflGdiI98eOodN9pR9vuOmVTTHrGl60u00223nPfXLOKri/DnXKHKIDY6oPIYyIz4Xx/LFmNQu9WhRX+7czUYiJQwqpqO6I3mMLR+HOW/G97epygWr6Ofza1e3fNeA91e7S6s0zfp/++yGZR+sN96sTPz1Ti83/Avm5pPuO7ciaLTzZKFULt/H8WaziRZE1iUxxYrm6Bv/BwewvyHeyylfTj0lQj2lPivPxtc1zHX/PTcHHDvb7t/fz9DWGAo1HNGLEtXegDo6f3tG/xtsvaU9fsIUf2F2QyhRVHBf05CeWRWPOxVMX/kFGkB8m89pxb+VSl8mcflfZ1BL4uKfzqD2B5PWANA=
jqJH7xDA5VPG70bS
